INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER

by B. Ya. Alekseev, A. A. Krasheninnikov, K. M. Nyushko, A. S. Kalpinsky, A. D. Kaprin
Published 2014-07-01

The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy

by I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, S. V. Mishugin
Published 2020-12-01

INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER

by B. Ya. Alekseev, A. A. Krasheninnikov, K. M. Nyushko, A. S. Kalpinsky, A. D. Kaprin
Published 2014-07-01

LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?

by V. B. Matveev, M. I. Volkova, D. Z. Kupchan, Ya. V. Gridneva
Published 2014-08-01

Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer

by A. I. Neimark, M. A. Tachalov, B. A. Neimark
Published 2014-11-01

LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?

by V. B. Matveev, M. I. Volkova, D. Z. Kupchan, Ya. V. Gridneva
Published 2014-08-01

Adjuvant hormone therapy in patients undergoing high-intensity focused ultrasound therapy for locally advanced prostate cancer

by A. I. Neimark, M. A. Tachalov, B. A. Neimark
Published 2014-11-01

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

by Tunn UW, Gruca D, Bacher P
Published 2013-04-01

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results

by Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, Takeru Kusumoto, Kentarou Kudou, Naoki Terakawa
Published 2021-06-01

Neuropathology and Therapeutic Intervention in Spinal and Bulbar Muscular Atrophy

by Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue
Published 2009-03-01

Producing flat-head grey mullet Mugil cephalus (Linnaeus, 1758) fries in captivity from sexually mature adults collected in Sardinian lagoons

by Dario Vallainc, Danilo Concu, Gemma Gimenez Papiol, Barbara Loi, Francesca Leggieri, Gianni Brundu, Anuta Chindris, Gabriele Sanna, Nicola Fois, Fabio Antognarelli, Paolo Rossini
Published 2021-11-01

Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice

by V. B. Matveev, A. S. Markova
Published 2016-06-01

Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Elig...

by V. B. Matveev, A. S. Markova
Published 2015-03-01

Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Elig...

by V. B. Matveev, A. S. Markova
Published 2015-03-01

Final results of the prospective multicenter observational program RU-EGD-NI-001 for evaluation of efficacy and tolerability of the 6-month depot Eligard 45 mg in patients with adv...

by V. B. Matveev, A. S. Markova
Published 2017-06-01